New rapid STI test aims to cut treatment wait times
NCT ID NCT07399873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a fast, point-of-care test for chlamydia and gonorrhea can reduce the time it takes for people to start antibiotics. Four hundred asymptomatic adults visiting a sexual health clinic will be randomly assigned to receive either the rapid test or a standard lab test. Researchers will measure how quickly treatment begins and how many people complete treatment within a week.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Point-of-care diagnostic test (Cobas Liat CT/NG Assay and CRISPR-based assay)
- What this could lead to
- If successful, this could make STI testing much faster, allowing people to get treated sooner and reducing the spread of infections.
- What could go wrong
- This is an early-stage trial focused on speed of treatment, not on curing or preventing disease. The new tests may not be as accurate as standard lab tests, and results may not apply to people with symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHLAMYDIA TRACHOMATIS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.